Clinical Trial Update: Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD

View source ↗

Summary

Long-term follow-up results from sub-retinal transplantation of human embryonic stem cell-derived retinal pigment epithelium cells in patients with age-related …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• hESC-derived retinal pigment epithelium cells (human embryonic stem cell-derived retinal pigment epithelium cells)

Snippet

Sponsor: Astellas Institute for Regenerative Medicine | Conditions: Age-Related Macular Degeneration | Status: COMPLETED